ARTICLE | Clinical News
Vatreptacog alfa: Phase IIIa started
August 15, 2011 7:00 AM UTC
Novo Nordisk disclosed in its 1H11 earnings that in July it began a double-blind, international Phase IIIa trial to compare vatreptacog alfa vs. NovoSeven in 60 patients. Novo Nordisk markets NovoSev...